We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$116M
AUM Growth
-$1.44M
Cap. Flow
-$1.6M
Cap. Flow %
-1.38%
Top 10 Hldgs %
24.2%
Holding
184
New
25
Increased
26
Reduced
81
Closed
25

Top Buys

Rank Stock Value
1
VLO icon
Valero Energy
VLO
+$1.1M
2
AZN icon
AstraZeneca
AZN
+$748K
3
NVS icon
Novartis
NVS
+$704K
4
AVT icon
Avnet
AVT
+$701K
5
SYNA icon
Synaptics
SYNA
+$698K

Top Sells

Rank Stock Value
1
MLM icon
Martin Marietta Materials
MLM
+$829K
2
TD icon
Toronto Dominion Bank
TD
+$755K
3
PVTB
PrivateBancorp Inc
PVTB
+$677K
4
BMY icon
Bristol-Myers Squibb
BMY
+$664K
5
WMT icon
Walmart Inc
WMT
+$646K

Sector Composition

Rank Sector Weight
1 Healthcare 19.02%
2 Industrials 16.07%
3 Consumer Staples 15.08%
4 Financials 12.64%
5 Consumer Discretionary 12.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHD icon
1
Church & Dwight Co
CHD
$23.4B
$5.94M 5.11%
115,400
-400
-0.3% -$19.3K
KMB icon
2
Kimberly-Clark
KMB
$36.3B
$3.4M 2.93%
24,738
-100
-0.4% -$13.1K
JNJ icon
3
Johnson & Johnson
JNJ
$618B
$3.07M 2.64%
25,280
-850
-3% -$96.6K
XOM icon
4
ExxonMobil
XOM
$644B
$3.05M 2.62%
32,526
-5,618
-15% -$497K
GE icon
5
GE Aerospace
GE
$374B
$2.59M 2.23%
17,142
-392
-2% -$57.2K
WASH icon
6
Washington Trust Bancorp
WASH
$743M
$2.43M 2.09%
64,093
-125
-0.2% -$4.66K
MRK icon
7
Merck
MRK
$322B
$2.2M 1.89%
39,954
-524
-1% -$27.9K
WFC icon
8
Wells Fargo
WFC
$261B
$2.05M 1.77%
43,397
+10,050
+30% +$490K
CELG
9
DELISTED
Celgene Corp
CELG
$1.75M 1.51%
17,755
-275
-2% -$28.4K
CSCO icon
10
Cisco
CSCO
$457B
$1.65M 1.42%
57,400
+6,450
+13% +$181K
MSFT icon
11
Microsoft
MSFT
$3.45T
$1.64M 1.41%
32,077
+8,575
+36% +$446K
DIS icon
12
Walt Disney
DIS
$167B
$1.58M 1.36%
16,175
-400
-2% -$40K
TFC icon
13
Truist Financial
TFC
$63.3B
$1.57M 1.35%
44,140
-2,000
-4% -$69.9K
INTC icon
14
Intel
INTC
$455B
$1.57M 1.35%
47,833
+7,300
+18% +$229K
PFE icon
15
Pfizer
PFE
$143B
$1.56M 1.34%
46,745
-1,960
-4% -$62.6K
VLO icon
16
Valero Energy
VLO
$90.1B
$1.53M 1.32%
30,000
+19,500
+186% +$1.1M
AMGN icon
17
Amgen
AMGN
$208B
$1.42M 1.22%
9,340
-275
-3% -$42.8K
NKE icon
18
Nike
NKE
$61.9B
$1.39M 1.2%
25,177
+3,375
+15% +$192K
MHK icon
19
Mohawk Industries
MHK
$7.5B
$1.37M 1.18%
7,220
+270
+4% +$52.5K
K
20
DELISTED
Kellanova
K
$1.33M 1.15%
17,394
-53
-0.3% -$3.8K
PRXL
21
DELISTED
Parexel International Corp
PRXL
$1.31M 1.13%
20,911
+3,725
+22% +$231K
AB icon
22
AllianceBernstein
AB
$3.43B
$1.31M 1.13%
56,238
+1,460
+3% +$34K
AAPL icon
23
Apple
AAPL
$4.54T
$1.3M 1.12%
54,360
+200
+0.4% +$4.97K
FDX icon
24
FedEx
FDX
$72.7B
$1.3M 1.12%
8,560
-1,240
-13% -$201K
BA icon
25
Boeing
BA
$171B
$1.27M 1.1%
9,800
-727
-7% -$94.8K
1
2 3 4 5

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return

New England Research & Management's Q2 2016 Portfolio in Review

As of Q2 2016, New England Research & Management held 184 positions worth $116M, down 1.2% from $118M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New England Research & Management's Q2 2016 filing shows 25 new, 26 increased, 81 reduced and 25 closed positions. Its largest new stake was AstraZeneca: 12,875 shares worth $777K. The largest sale was Martin Marietta Materials, an estimated $829K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Industrials and Consumer Staples.

  • New England Research & Management's largest Q2 2016 buy was AstraZeneca: 12,875 shares worth $777K.
  • New England Research & Management added most to Valero Energy in Q2 2016, an estimated $1.1M increase.
  • New England Research & Management's biggest Q2 2016 reduction was Bristol-Myers Squibb, cutting an estimated $664K.
  • New England Research & Management fully exited Martin Marietta Materials in Q2 2016, selling an estimated $829K.
  • New England Research & Management's ten largest holdings make up 24% of its $116M portfolio in Q2 2016.
  • New England Research & Management opened 25 new positions and closed 25 in Q2 2016.
  • New England Research & Management's portfolio value fell 1.2% quarter-over-quarter to $116M.

Based on New England Research & Management's 13F filing for Q2 2016, filed 5 Jul 2016.